• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[精氨酸 - 赖氨酸 - 乳糖治疗绝经后骨质疏松症的经验]

[Experience regarding the use of arginine-lysine-lactose treatment in menopausal osteoporosis].

作者信息

Bellati U, Liberati M

机构信息

Clinica Ostetrica e Ginecologica, Università degli Studi, G. D'Annunzi, Cheti.

出版信息

Minerva Med. 1994 Jun;85(6):327-32.

PMID:8084436
Abstract

Two matched groups of postmenopausal patients were treated respectively with calcitonin or calcitonin and an arginine-lysine-glycerophosphoric acid-lactose association. The rationale underlying this therapy took the form of data in the literature which indicated an action of these amino acids and lactose on calcium absorption and on the metabolism of protein components in the skeletal structure. The following tests were performed: mineralometric evaluation, evaluation of painful symptoms and intake of pain-relieving drugs, serum levels of calcium, phosphorus, alkaline phosphatase, osteocalcin, parathormone, and calciuria and hydroxyproline. These parameters were assayed at the beginning and end of treatment which lasted six months. The results, or in other words the comparison between the two groups, basal or after treatment, and the values recorded before and after treatment in each group, enable the authors to affirm that the administration of the arginine-lysine-glycerophosphoric acid-lactose association leads to an increase in bone density and plasma osteocalcin, a reduction in painful symptoms and analgesic intake, and a reduction in the serum levels of parathromone and hydroxyproline. Data reported in the literature support the conclusion that the results obtained are the consequence of an improved intestinal absorption calcium. It is highly probable that the protein components of the association administered, arginine-lysine-glycerophosphoric acid-lactose, also exercise a direct action on osteoblasts and on the metabolism of bone matrix protein components.

摘要

将两组匹配的绝经后患者分别用降钙素或降钙素与精氨酸 - 赖氨酸 - 甘油磷酸 - 乳糖组合进行治疗。这种治疗的基本原理源于文献中的数据,这些数据表明这些氨基酸和乳糖对钙吸收以及骨骼结构中蛋白质成分的代谢有作用。进行了以下测试:矿物质评估、疼痛症状评估和止痛药物摄入量、血清钙、磷、碱性磷酸酶、骨钙素、甲状旁腺激素水平,以及尿钙和羟脯氨酸。这些参数在为期六个月的治疗开始和结束时进行测定。结果,换句话说,两组之间、治疗前后的比较以及每组治疗前后记录的值,使作者能够肯定,给予精氨酸 - 赖氨酸 - 甘油磷酸 - 乳糖组合会导致骨密度和血浆骨钙素增加,疼痛症状和止痛药物摄入量减少,以及血清甲状旁腺激素和羟脯氨酸水平降低。文献报道的数据支持这样的结论,即所获得的结果是肠道钙吸收改善的结果。很可能所给予组合中的蛋白质成分,即精氨酸 - 赖氨酸 - 甘油磷酸 - 乳糖,也对成骨细胞和骨基质蛋白质成分的代谢有直接作用。

相似文献

1
[Experience regarding the use of arginine-lysine-lactose treatment in menopausal osteoporosis].[精氨酸 - 赖氨酸 - 乳糖治疗绝经后骨质疏松症的经验]
Minerva Med. 1994 Jun;85(6):327-32.
2
[The effects of the carbocalcitonin + arginine-lysine-lactose combination in senile involutional osteoporosis].[降钙素原+精氨酸-赖氨酸-乳糖组合对老年性退行性骨质疏松症的影响]
Minerva Med. 1994 May;85(5):253-9.
3
[Experimental osteoporosis caused by estrogen deficiency in rats. Role of a lactose, L-arginine and L-lysine combination in the prevention and therapy].[大鼠雌激素缺乏所致实验性骨质疏松。乳糖、L-精氨酸和L-赖氨酸组合在预防和治疗中的作用]
Minerva Med. 1996 Mar;87(3):81-8.
4
Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
Int J Tissue React. 1999;21(2):51-9.
5
[Role of lactose, arginine and lysine combination in fracture healing (an experimental study)].乳糖、精氨酸和赖氨酸组合在骨折愈合中的作用(一项实验研究)
Ann Ital Chir. 1996 Jan-Feb;67(1):77-82; discussion 82-3.
6
Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.阿仑膦酸钠与吲达帕胺单独或联合用于治疗与骨质疏松症相关的高钙尿症:两种药物和三种治疗方案的随机对照试验
Nephrol Dial Transplant. 2009 May;24(5):1472-7. doi: 10.1093/ndt/gfn690. Epub 2008 Dec 15.
7
Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.在评估阿仑膦酸盐和降钙素对绝经后骨质疏松症患者骨骼的影响时,锌排泄与骨重塑生化标志物的比较
Clin Biochem. 2005 Jan;38(1):66-72. doi: 10.1016/j.clinbiochem.2004.10.001.
8
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate].
Minerva Ginecol. 1996 Jun;48(6):263-72.
9
[Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].[17-β-雌二醇与降钙素对绝经后骨质流失女性的疗效比较]
Cas Lek Cesk. 1997 Apr 16;136(8):242-8.
10
The effect of calcitonin treatment on plasma nitric oxide levels in post-menopausal osteoporotic patients.降钙素治疗对绝经后骨质疏松症患者血浆一氧化氮水平的影响。
Cell Biochem Funct. 2002 Jun;20(2):103-5. doi: 10.1002/cbf.959.

引用本文的文献

1
Metabolomics Based Profiling of Dexamethasone Side Effects in Rats.基于代谢组学的大鼠地塞米松副作用分析
Front Pharmacol. 2018 Feb 16;9:46. doi: 10.3389/fphar.2018.00046. eCollection 2018.